Abstract
Myocardial bridging (MB) is a congenital coronary anomaly where segment of the epicardial coronary artery traverses through the myocardium for a portion of its length. While traditionally regarded as a benign condition, there is a growing focus on specific subsets of MB associated with ischemic symptoms and requires treatment. Increasing attention is being given to specific subsets of MB associated with ischemic symptomatology. The emergence of modern functional and anatomical imaging techniques; coronary angiography, coronary computed tomography angiography (CCTA), instantaneous wave-free ratio (iFR), dan diastolic fractional flow reserve (dFFR), has improved our capacity to characterize symptoms associated with MB. In cases involving symptomatic patients, medical therapy often represents an effective treatment option. For individuals who do not respond satisfactorily to medical interventions, comprehensive multimodal assessment; percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG), and myotomy should be considered.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
